James C Mullen Editas Medicine, Inc. (EDIT) insider trading activity

EDIT Quotes by TradingView

James C Mullen is CEO of Editas Medicine, Inc.. Currently has a direct ownership of 75,898 shares of EDIT, which is worth approximately $167,734. The most recent transaction as insider was on Jan 03, 2022, when has been sold 18,252 shares (Common Stock) at a price of $26.95 per share, resulting in proceeds of $491,891. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75.9K
0% 3M change
0% 12M change
Total Value Held $167,734

JAMES C MULLEN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 03 2022
SELL
Open market or private sale
$491,891 $26.95 p/Share
18,252 Reduced 19.39%
75,898 Common Stock
Dec 22 2021
BUY
Grant, award, or other acquisition
-
36,477 Added 27.92%
94,150 Common Stock
Oct 18 2021
SELL
Open market or private sale
$525,004 $38.03 p/Share
13,805 Reduced 19.31%
57,673 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
-
36,478 Added 33.79%
71,478 Common Stock
Mar 02 2021
BUY
Open market or private purchase
$1,156,750 $46.27 p/Share
25,000 Added 41.67%
35,000 Common Stock

Also insider at

TMO
THERMO FISHER SCIENTIFIC INC. Healthcare
Director
JCM

James C Mullen

CEO
Waltham, MA

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EDIT